Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | SQZ-PBMC-HPV |
Synonyms | |
Therapy Description |
SQZ-PBMC-HPV are autologous peripheral blood mononuclear cells that are engineered to express antigens specific to HPV16 type E6 and E7, which may result in enhanced immune response against HPV16 E6 and E7-expressing tumor cells NCI Drug Dictionary). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
SQZ-PBMC-HPV | SQZ-PBMC-HPV are autologous peripheral blood mononuclear cells that are engineered to express antigens specific to HPV16 type E6 and E7, which may result in enhanced immune response against HPV16 E6 and E7-expressing tumor cells NCI Drug Dictionary). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT04084951 | Phase I | SQZ-PBMC-HPV Atezolizumab + SQZ-PBMC-HPV | Study of SQZ-PBMC-HPV in Patients With HPV16+ Recurrent, Locally Advanced or Metastatic Solid Tumors | Completed | USA | DEU | CAN | 0 |